1. Home
  2. UXIN vs RCUS Comparison

UXIN vs RCUS Comparison

Compare UXIN & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UXIN
  • RCUS
  • Stock Information
  • Founded
  • UXIN 2011
  • RCUS 2015
  • Country
  • UXIN China
  • RCUS United States
  • Employees
  • UXIN N/A
  • RCUS N/A
  • Industry
  • UXIN Business Services
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • UXIN Consumer Discretionary
  • RCUS Health Care
  • Exchange
  • UXIN Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • UXIN 821.3M
  • RCUS 727.1M
  • IPO Year
  • UXIN 2018
  • RCUS 2018
  • Fundamental
  • Price
  • UXIN $4.64
  • RCUS $8.54
  • Analyst Decision
  • UXIN
  • RCUS Buy
  • Analyst Count
  • UXIN 0
  • RCUS 11
  • Target Price
  • UXIN N/A
  • RCUS $25.33
  • AVG Volume (30 Days)
  • UXIN 29.0K
  • RCUS 1.3M
  • Earning Date
  • UXIN 04-30-2025
  • RCUS 05-06-2025
  • Dividend Yield
  • UXIN N/A
  • RCUS N/A
  • EPS Growth
  • UXIN N/A
  • RCUS N/A
  • EPS
  • UXIN N/A
  • RCUS N/A
  • Revenue
  • UXIN $273,130,591.00
  • RCUS $141,000,000.00
  • Revenue This Year
  • UXIN N/A
  • RCUS N/A
  • Revenue Next Year
  • UXIN N/A
  • RCUS $25.77
  • P/E Ratio
  • UXIN N/A
  • RCUS N/A
  • Revenue Growth
  • UXIN 42.47
  • RCUS N/A
  • 52 Week Low
  • UXIN $1.41
  • RCUS $6.50
  • 52 Week High
  • UXIN $7.84
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • UXIN 52.10
  • RCUS 51.16
  • Support Level
  • UXIN $3.87
  • RCUS $8.34
  • Resistance Level
  • UXIN $4.98
  • RCUS $9.00
  • Average True Range (ATR)
  • UXIN 0.47
  • RCUS 0.55
  • MACD
  • UXIN -0.03
  • RCUS 0.06
  • Stochastic Oscillator
  • UXIN 50.00
  • RCUS 64.63

About UXIN Uxin Limited ADS

Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: